Full-Time

Sr Full Stack Developer

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Full-Stack Engineering
Software Engineering
Required Skills
Agile
Python
JavaScript
React.js
NoSQL
Software Testing
Node.js
SQL
Microservices
SCRUM
Requirements
  • Master’s degree with 4 - 6 years of experience in Computer Science, IT or related field
  • Bachelor’s degree with 6 - 8 years of experience in Computer Science, IT or related field
  • Diploma with 10 - 12 years of experience in Computer Science, IT or related field
  • Proficiency with Full Stack software development
  • Proficiency in programming languages Python (preferred), JavaScript, SQL/NoSQL
  • Experience with modern front-end frameworks and libraries (e.g., React, Node.js)
  • Experienced with API integration, serverless, microservices architecture
  • Experience with version control and CI/CD using GitLab
  • Experience with various cloud services, understanding pros and cons of various cloud services in well-architected cloud design principles
  • Strong problem-solving and analytical skills; Ability to learn quickly; Superb communication and interpersonal skills
  • Good understanding of software development methodologies, including Agile and Scrum
Responsibilities
  • Lead full-stack web-based application development for various components of our regulatory submission capability
  • Lead a team of programmers while also willing to jump in and code based on project demands
  • Take ownership of complex software projects from conception to deployment
  • Manage software delivery scope, risk, and timeline
  • Rapidly prototype concepts into working code
  • Provide technical guidance and mentorship to junior developers
  • Contribute to front-end and back-end development using cloud technology
  • Develop innovative solutions using generative AI technologies
  • Integrate with other systems and platforms to ensure seamless data flow and functionality
  • Conduct code reviews to ensure code quality and alignment to standard processes
  • Create and maintain documentation on software architecture, design, deployment, disaster recovery, and operations
  • Analyze and understand the functional and technical requirements of applications, solutions, and systems and translate them into software architecture and design specifications
  • Work closely with product team, multi-functional teams, enterprise technology teams and QA, to deliver high-quality and compliant software on time
  • Ensure high quality software deliverables free of bugs and performance issues through proper design and comprehensive testing strategies
  • Customize modules to meet specific business requirements
  • Provide ongoing support and maintenance for applications, ensuring that they operate smoothly and efficiently
  • Stay updated with the latest trends and advancements
Desired Qualifications
  • Good understanding of cloud platforms (e.g., AWS, GCP, Azure) and containerization technologies (e.g., Docker, Kubernetes)
  • Experience with monitoring and logging tools (e.g., Prometheus, Grafana, Splunk)
  • Experience with data processing tools like Hadoop, Spark, or similar
  • Experience with Langchain or llamaIndex framework for language models; Experience with prompt engineering, model fine-tuning
  • Experience in SQL/NoSQL database, vector database for large language models
  • Experience with popular large language models
  • AWS Certified Developer (preferred)

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen stands out from competitors by reinvesting a large portion of its earnings into research and development, ensuring a strong pipeline of new treatments. The goal of Amgen is to improve patient care and address critical health challenges through its innovative therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.